Matthew Vincent Dolan, SVP Corporate Strategy-Develop at DEXCOM INC (DXCM), sold 2,303 shares at $115.00 ($265K) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $265k DXCM by SVP Corporate Strategy-Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DXCM | SELL | 2024-04-16 | $548K | — | Filing → |
| DXCM | SELL | 2024-03-19 | $1.1M | — | Filing → |
| DXCM | SELL | 2024-03-14 | $1.8M | — | Filing → |